Activist & passive stakes
Investors crossing the 5% ownership line, from SEC Schedule 13D (activist) and 13G (passive) filings. Newest first.
Showing the last 10 days.Sign up free for 90 days
Amendments only.1–9 of 9
- PassiveAmendment 1Nov 6, 2026Boxer Capital Management, LLC7.9% · 2,357,922 shSEC
- PassiveAmendment 1Below 5%Nov 6, 2026Jane Street Group, Llc2.8% · 8,161,276 shSEC
- PassiveAmendment 1Nov 6, 2026T. Rowe Price Investment Management, Inc.10.3% · 9,996,124 shSEC
- PassiveAmendment 18Nov 6, 2026Primecap Management Co/Ca/13.29% · 9,879,855 shSEC
- PassiveAmendment 1Below 5%Nov 5, 2026Xencor, Inc.1.5% · 1,000,000 shSEC
- PassiveAmendment 4Nov 5, 2026Primecap Management Co/Ca/7% · 2,462,873 shSEC
- PassiveAmendment 9Nov 5, 2026Fmr Llc11.5% · 11,136,649 shSEC
- PassiveAmendment 1Below 5%Oct 30, 2026Vanguard Capital Management4.99% · 3,710,894 shSEC
- PassiveAmendment 1Below 5%Oct 30, 2026Vanguard Capital Management4.98% · 9,086,791 shSEC
| Filing | Symbol | Holder | % Owned | Shares | Filed | SEC filing |
|---|---|---|---|---|---|---|
PassiveAmendment 1 | QTTB | Boxer Capital Management, LLC in Q32 Bio Inc. | 7.9% | 2,357,922 | Nov 6, 2026 | SEC |
PassiveAmendment 1Below 5% | XE | Jane Street Group, Llc in X-Energy, Inc. | 2.8% | 8,161,276 | Nov 6, 2026 | SEC |
PassiveAmendment 1 | XENE | T. Rowe Price Investment Management, Inc. in Xenon Pharmaceuticals Inc | 10.3% | 9,996,124 | Nov 6, 2026 | SEC |
PassiveAmendment 18 | XNCR | Primecap Management Co/Ca/ in Xencor Inc | 13.29% | 9,879,855 | Nov 6, 2026 | SEC |
PassiveAmendment 1Below 5% | ZBIO | Xencor, Inc. in Zenas BioPharma, Inc. | 1.5% | 1,000,000 | Nov 5, 2026 | SEC |
PassiveAmendment 4 | MKTX | Primecap Management Co/Ca/ in Marketaxess Holdings Inc | 7% | 2,462,873 | Nov 5, 2026 | SEC |
PassiveAmendment 9 | XENE | Fmr Llc in Xenon Pharmaceuticals Inc | 11.5% | 11,136,649 | Nov 5, 2026 | SEC |
PassiveAmendment 1Below 5% | XNCR | Vanguard Capital Management in Xencor Inc | 4.99% | 3,710,894 | Oct 30, 2026 | SEC |
PassiveAmendment 1Below 5% | XERS | Vanguard Capital Management in Xeris Biopharma Holdings Inc | 4.98% | 9,086,791 | Oct 30, 2026 | SEC |